                         SEQUENCE LISTING

<110>  Intarcia Therapeutics, Inc.
 
<120>  METHODS COMPRISING CONTINUOUS ADMINISTRATION OF A GLP-1 RECEPTOR 
       AGONIST AND CO-ADMINSTRATION OF A DRUG

<130>  ITCA-052/001WO 023303-3379

<150>  62/441,833
<151>  2017-01-03

<160>  1     

<170>  PatentIn version 3.5

<210>  1
<211>  39
<212>  PRT
<213>  Heloderma suspectum

<400>  1

His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
1               5                   10                  15      


Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


